Cell Therapy

CHICAGO — In this video, Shahzad Raza, MD, discusses safety and efficacy data from Nexicart-2, which studied the use of chimeric antigen receptor T-cell therapy in relapsed or refractory light chain amyloidosis.

The ASTCT Translational Science Training Course is designed to meet a critical need in cellular therapy by providing structured support for early-stage researchers in laboratory and translational science.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following CD19-directed CAR-T, according to results of a phase 1 study.

The American Society for Transplantation and Cellular Therapy is proud to announce the release of a refreshed Practice Guidelines mobile app.

An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor therapies used to treat cancers, according to recent findings.

CHICAGO — Lisocabtagene maraleucel significantly improved responses rates and survival outcomes among patients with relapsed or refractory chronic lymphocytic leukemia, according to findings presented at ASCO Annual Meeting.

CHICAGO — Healio | HemOnc Today hosted its fourth Disruptive Innovators Awards ceremony, crowning nine new winners at ASCO Annual Meeting.

Immunoengineering, which has been beneficial to other medical specialties, could be used in the infectious diseases field to help treat a variety of potentially deadly infections by boosting patient immunity, researchers said.

There are limits to cell therapy delivery in patients requiring extracorporeal membrane oxygenation due to the machine, but Consecutive Intrabronchial Administration offers a potential new delivery route, according to a press release.